Name | Value |
---|---|
Revenues | 5,263.0K |
Cost of Revenue | 2,907.0K |
Gross Profit | 2,356.0K |
Operating Expense | 2,356.0K |
Operating I/L | -3,932.0K |
Other Income/Expense | -843.0K |
Interest Income | 0.0K |
Pretax | -4,775.0K |
Income Tax Expense | -776.0K |
Net Income/Loss | -3,999.0K |
ImmunoPrecise Antibodies Ltd. is a leading provider of antibody production and related services globally. The company offers a diverse range of antibodies, enzymes, proteins, and hybridoma products for research purposes. Its contract research organization services encompass custom antigen modeling, B cell sorting, antibody engineering, and cell line generation. ImmunoPrecise Antibodies has research collaboration agreements with industry leaders for antibody discovery and high-concentration formulation of COVID-19 antibody cocktails. The company generates revenue through the sale of its antibody products, contract research services, and collaborative research agreements.